Alvotech files 6-K

Alvotech announced that the U.S. Food and Drug Administration (FDA) completed a routine cGMP surveillance inspection of its manufacturing facility in Reykjavik, Iceland, and issued a Form 483. This report is being furnished as part of the company's monthly reporting.